Australia markets open in 8 hours 36 minutes

Easywell Biomedicals, Inc. (1799.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
70.10-0.20 (-0.28%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
271,628
271,628
178,897
197,277
267,654
Cost of revenue
100,910
100,910
102,583
146,847
183,693
Gross profit
170,718
170,718
76,314
50,430
83,961
Operating expenses
Research development
271,499
271,499
209,411
238,143
221,610
Selling general and administrative
61,957
61,957
28,161
24,149
21,211
Total operating expenses
333,456
333,456
237,572
262,292
242,821
Operating income or loss
-162,738
-162,738
-161,258
-211,862
-158,860
Interest expense
19,258
19,258
17,246
16,082
16,073
Income before tax
-169,909
-169,909
-168,275
-169,660
-182,819
Income tax expense
256
256
119
849
2,027
Income from continuing operations
-170,165
-170,165
-168,394
-170,509
-184,846
Net income
-144,818
-144,818
-161,000
-150,391
-173,412
Net income available to common shareholders
-144,818
-144,818
-161,000
-150,391
-173,412
Basic EPS
-1.27
-
-1.39
-1.44
-1.84
Diluted EPS
-1.27
-
-1.39
-1.44
-1.84
Basic average shares
115,624
-
115,440
104,123
94,294
Diluted average shares
115,624
-
115,440
104,123
94,294